Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines

RJM De Vries, DJ Van Veldhuisen… - American heart …, 2000 - Elsevier
Background Chronic heart failure (CHF) has high morbidity and mortality rates despite
treatment with angiotensin-converting enzyme inhibitors, diuretics, and digoxin. Adjunctive …
被引用次数：70 相关文章

[引用][C] Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines

RJM DE VRIES, DJ VAN VELDHUISEN… - The American heart …, 2000 - pascal-francis.inist.fr
Efficacy and safety of calcium channel blockers in heart failure : Focus on recent trials with
second-generation dihydropyridines CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.

RJ de Vries, DJ van Veldhuisen… - American Heart …, 2000 - europepmc.org
Background Chronic heart failure (CHF) has high morbidity and mortality rates despite
treatment with angiotensin-converting enzyme inhibitors, diuretics, and digoxin. Adjunctive …

Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines

RJM de Vries, DJ van Veldhuisen… - American Heart …, 2000 - research.rug.nl
Background Chronic heart failure (CHF) has high morbidity and mortality rates despite
treatment with angiotensin-converting-enzyme inhibitors, diuretics, and digoxin. Adjunctive …

Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines

RJ de Vries, DJ van Veldhuisen… - American heart …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Chronic heart failure (CHF) has high morbidity and mortality rates despite
treatment with angiotensin-converting enzyme inhibitors, diuretics, and digoxin. Adjunctive …

Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines

RJM de Vries, DJ van Veldhuisen… - American Heart …, 2000 - infona.pl
Background Chronic heart failure (CHF) has high morbidity and mortality rates despite
treatment with angiotensin-converting enzyme inhibitors, diuretics, and digoxin. Adjunctive …

[引用][C] Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines

RJM DE VRIES, DJ VAN VELDHUISEN… - The American heart …, 2000 - Mosby